First human test begins for new drug candidate
NCT ID NCT07182552
Summary
This is a very early study to see if a new injection called NTB003 is safe for people and to learn how the body handles it. It will involve 40 healthy volunteers who will receive different doses. The main goal is to check for side effects and measure the drug's levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aerospace Center Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.